Non-alcoholic steatohepatitis is a significant progressive disease from simple fatty liver disease, marked by the presence of liver cell injury and inflammation alongside fat accumulation in the liver. Unlike alcoholic liver disease, this occurs in individuals who consume little to no alcohol. The condition is associated with other conditions like obesity, insulin resistance, type 2 diabetes, or metabolic syndrome. If left unmanaged, it can lead to fibrosis, cirrhosis, liver cancer, and eventually liver failure.
Emerging Therapies for Non-Alcoholic Steatohepatitis (NASH) - An Overview
In recent times, many novel therapies have been researched and developed for non-alcoholic steatohepatitis. Read the article to learn more.
Non-Alcoholic Steatohepatitis(NASH) - Symptoms, Stages, Risks, Diagnosis and Management
NASH, abbreviated for non-alcoholic steatohepatitis, is a silent liver disease. Read below to acquire in-depth details about NASH.
Alcoholic and Non-Alcoholic Steatohepatitis
Alcoholic steatohepatitis occurs due to excessive consumption of alcohol, whereas non-alcoholic steatohepatitis occurs due to excessive fat buildup in the liver.
